DIVISLAB

The company's recent financial performance reveals a mixed but overall positive trend. Consolidated revenue for the quarter-ending June 2025 stood at Rs 2,410 Crore, up from Rs 2,118 Crore in June 2024. Net profit for the same period was Rs 545 Crore, compared to Rs 430 Crore in the corresponding quarter of the previous year. The EPS for June 2025 was Rs 20.49, higher than the Rs 16.20 reported in June ***** annual consolidated revenue for the year-ending March 2025 was Rs 9,360 Crore, a notable increase from Rs 7,845 Crore in the previous year. Net profit also saw a rise, reaching Rs 2,191 Crore in March 2025 compared to Rs 1,600 Crore in March 2024. The Earnings Per Share (EPS) increased from Rs 60.27 in 2024 to Rs 82.53 in ***** financial details from the annual income statement show sales increasing from Rs 7,845 Crore in March 2024 to Rs 9,360 Crore in March 2025. Other income rose from Rs 339 Crore to Rs 352 Crore. Total expenditure increased from Rs 6,018 Crore to Rs 6,794 Crore, and EBIT increased from Rs 2,166 Crore to Rs 2,918 Crore. Key financial ratios reveal a P/E ratio of 69.98 and a P/B ratio of 10.22 as of March 2025. The company's debt-to-equity ratio remains at 0.00, indicating a debt-free status.